<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>pharmalicensing.com: Industry news</title>
		<link>http://pharmalicensing.com/rss/</link>
		<description>Latest market and business intelligence from the leading publishers worldwide.</description>
		<language>en-us</language>
		<image>
			<title>pharmalicensing.com: Industry news</title>
			<link>http://pharmalicensing.com/rss/</link>
			<url>http://pharmalicensing.com/images/pharmalicensing_logo.jpg</url>
			<width>144</width>
		</image>
								<item>
				<title>Warnex Reports Fourth Quarter and Year End 2009 Results</title>
				<description>Laval, QC, March 18, 2010 - Warnex Inc. (TSX: WNX) announced today financial results for the fourth quarter and year ended December 31, 2009.</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/512508/3/0/</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/512508/3/0/</guid>
			</item>
					<item>
				<title>Stellar Pharmaceuticals Allowed Uracyst(R) Patent in China</title>
				<description>LONDON, ONTARIO-- March 17, 2010 - Stellar Pharmaceuticals Inc. (OTCBB:SLXCF) (&quot;Stellar&quot; or &quot;the Company&quot;), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products...</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/512482/3/0/</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/512482/3/0/</guid>
			</item>
					<item>
				<title>BIOMS MEDICAL ANNOUNCES 2009 YEAR END RESULTS</title>
				<description>Edmonton, Alberta, March 16, 2010 - BioMS Medical Corp. (TSX: MS), today announced financial and operational results for the year ended December 31, 2009.</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/512600/3/0/</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/512600/3/0/</guid>
			</item>
					<item>
				<title>Unigene Reports Financial Results for Fourth Quarter and Year-End 2009</title>
				<description>BOONTON, N.J., Mar 16, 2010 -- Unigene Laboratories, Inc. (OTCBB: UGNE, http://www.unigene.com) has reported its financial results for the quarter and year ended December 31, 2009.</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/512520/3/0/</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/512520/3/0/</guid>
			</item>
					<item>
				<title>Exelixis Announces March 24 Webcast of Presentation at the Barclays Capital Global Healthcare Conference</title>
				<description>SOUTH SAN FRANCISCO, Calif., Mar 16, 2010 -- Exelixis, Inc. (NASDAQ: EXEL) announced today that Frank Karbe, the company&#039;s executive vice president and chief financial officer, will present at the...</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/512305/3/0/</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/512305/3/0/</guid>
			</item>
					<item>
				<title>MDS Reports First Quarter Fiscal 2010 Financial Results</title>
				<description>OTTAWA, March 16, 2010 -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global health science markets, today reported financial results and filed its unaudited...</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/512081/3/0/</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/512081/3/0/</guid>
			</item>
					<item>
				<title>Sequenom Reports 2009 Fourth Quarter and Full Year Financial Results</title>
				<description>SAN DIEGO, March 15, 2010 -- Sequenom, Inc. (Nasdaq: SQNM) today reported its financial results for the fourth quarter and year ended December 31, 2009.</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/512576/3/0/</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/512576/3/0/</guid>
			</item>
					<item>
				<title>Medivation Reports Fourth Quarter and Year-End 2009 Financial Results and Provides Corporate Update</title>
				<description>SAN FRANCISCO, March 15, 2010 -- Medivation, Inc. (Nasdaq: MDVN) today provided a corporate update and reported its financial results for the year ended December 31, 2009.</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/512030/3/0/</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/512030/3/0/</guid>
			</item>
					<item>
				<title>GeneNews Reports Fourth Quarter and 2009 Annual Results</title>
				<description>TORONTO, CANADA (March 15, 2010): GeneNews Limited (TSX: GEN), an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized...</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/512077/3/0/</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/512077/3/0/</guid>
			</item>
					<item>
				<title>Pacific Biomarkers, Inc. Awarded Major Research Contract As Part Of Innovative Diabetes Program</title>
				<description>Seattle, Washington - March 15, 2010- Pacific Biomarkers, Inc.(&quot;PBI&quot;) (OTCBB: PBMC), which provides specialized central laboratory and contract research services to support pharmaceutical and...</description>
				<link>http://pharmalicensing.com/redirs/news_rss//public/news/view/512115/3/0/</link>
				<guid>http://pharmalicensing.com/redirs/news_rss//public/news/view/512115/3/0/</guid>
			</item>
					<atom:link href="http://pharmalicensing.com/public/public/news/latest/3/0.rss" rel="self" type="application/rss+xml" />
	</channel>
</rss>
